İçeriğe geç
akaturk Akademik ölçüm
Giriş Kayıt

Akademisyen

ALİ İRFAN EMRE TEKGÜNDÜZ

PROFESÖR

MALTEPE ÜNİVERSİTESİ TIP FAKÜLTESİ DAHİLİ TIP BİLİMLERİ BÖLÜMÜ

  • Ana Dal Sağlık Bilimleri Temel Alanı
  • Yan Dal Hematoloji (İç Hastalıkları)

Kayıtlı çıktılara kısa bakış — ayrıntılar aşağıda.

  • Makale 59
  • Proje 0
  • Kitap 0
  • Bildiri 0
  • Patent 0
  • Sanatsal 0
Scopus (SJR) Q1 7 Q2 4 Q3 37 Q4 7
WoS (JCR) Q1 3 Q2 4 Q3 6 Q4 42
TR Index 6 makale

Alan+yıl+tür normalize OpenAlex yüzdelik — Clarivate ESI / SciVal değildir.

Üst %1 makale 0
Üst %10 makale 3
Ort. yüzdelik 51.6%
Üst %1 payı 0.0%
Üst %10 payı 5.2%

Makaleler

YÖKSİS ve OpenAlex kaynak ayrımıyla makaleler; quartile ve TR Index ile daraltabilirsiniz.

Dizin filtreleri

Toplam 59 yayın

Scopus (SJR)
Q1 7 Q2 4 Q3 37 Q4 7
WoS (JCR)
Q1 3 Q2 4 Q3 6 Q4 42
TR Index
6 makale

Makale listesi

  1. 2022 Extracorporeal photopheresis in the treatment of acute and chronic graft-versus-host disease: A position statement from the Turkish Society of Apheresis (TSA) TRANSFUSION AND APHERESIS SCIENCE DOI 10.1016/j.transci.2022.103373 YÖKSİS SJR Q3 JCR Q4 OpenAlex 76.6%
  2. 2022 Prospective registry of adult patients receiving therapeutic plasma exchange with a presumptive diagnosis of thrombotic microangiopathy (TMA): the Turkish hematology research and education group (ThREG)-TMA02 study Elsevier BV DOI 10.1016/j.transci.2022.103365 YÖKSİS SJR Q3 JCR Q4 OpenAlex 31.9%
  3. 2022 Real-Life Experience Regarding Clinical Characteristics and Treatment Outcome in Non-Cutaneous Peripheral T-Cell Lymphomas: A Multicenter Study of the Turkish Hematology Research and Education Group (ThREG) Galenos Yayinevi DOI 10.4274/tjh.galenos.2022.2022.0052 YÖKSİS TR Index SJR Q3 JCR Q3 OpenAlex 7.8%
  4. 2020 Early Access Program Results From Turkey and a Literature Review on Daratumumab Monotherapy Among Heavily Pretreated Patients With Relapsed/Refractory Myeloma Clinical Lymphoma Myeloma & Leukemia DOI 10.1016/j.clml.2020.02.017 YÖKSİS SJR Q2 JCR Q3 OpenAlex 81.5%
  5. 2020 Incidence and risk factors for hepatic sinusoidal obstruction syndrome after allogeneic hematopoietic stem cell transplantation: A retrospective multicenter study of Turkish hematology research and education group (ThREG) Transfusion and Apheresis Science DOI 10.1016/j.transci.2020.102827 YÖKSİS SJR Q3 JCR Q4 OpenAlex 80.3%
  6. 2020 The effect of high-dose cytarabine followed by autologous hematopoietic stem cell transplantation on the outcome of patients with mantle cell lymphoma Journal of Oncology Pharmacy Practice DOI 10.1177/1078155219841110 YÖKSİS SJR Q3 JCR Q4 OpenAlex 54.6%
  7. 2019 Assessment of ovarian reserve with anti-Mullerian hormone in women following allogeneic hematopoietic cell transplantation CLINICAL AND EXPERIMENTAL OBSTETRICS GYNECOLOGY DOI 10.12891/ceog4552.2019 YÖKSİS SJR Q3 JCR Q4 OpenAlex 31.4%
  8. 2019 Impacts of Post-Transplantation Cyclophosphamide Treatment After Allogeneic Hematopoietic Stem Cell Transplantation in Acute Myeloid Leukemia Scientific Reports DOI 10.1038/s41598-019-38644-1 YÖKSİS SJR Q1 JCR Q1 OpenAlex 79.6%
  9. 2018 Efficacy of CLARA in Recurrent/Refractory Acute Myeloid Leukaemia Patients Unresponsive to FLAG Chemotherapy Journal of Chemotherapy DOI 10.1080/1120009X.2017.1396017 YÖKSİS SJR Q2 JCR Q4 OpenAlex 63.4%
  10. 2018 A multicenter experience of thrombotic microangiopathies in Turkey: The Turkish Hematology Research and Education Group (ThREG)-TMA01 study Transfusion and Apheresis Science DOI 10.1016/j.transci.2018.02.012 YÖKSİS SJR Q3 JCR Q4 OpenAlex 52.4%
  11. 2018 Impact of Guideline-Driven Approach in Follow-Up of Long-Term Complications After Allogeneic Hematopoietic Cell Transplant: Single Center Experience. Experimental and Clinical Transplantation DOI 10.6002/ect.2018.0007 YÖKSİS SJR Q3 JCR Q4 OpenAlex 21.8%
  12. 2018 Stem cell mobilization kinetics in elderly patients with multiple myeloma Transfusion and Apheresis Science DOI 10.1016/j.transci.2018.01.010 YÖKSİS SJR Q3 JCR Q4 OpenAlex 2.6%
  13. 2017 Invasive aspergillosis with disseminated skin ınvolvement in a patient with acute myeloid leukemia: a rare case Hematology Reports DOI 10.4081/hr.2017.6997 YÖKSİS SJR Q3 JCR Q4 OpenAlex 48.8%
  14. 2017 Nivolumab for relapsed or refractory Hodgkin lymphoma: real-life experience Annals of Oncology DOI 10.1093/annonc/mdx341 YÖKSİS SJR Q1 JCR Q1 OpenAlex üst %10 OpenAlex 97.8%
  15. 2017 Risk Adapted Management of Febrile Neutrepenia and Early Cessation of Empirical Antibiotherapy in Hematopoietic Stem Cell Transplantation Setting Balkan Medical Journal DOI 10.4274/balkanmedj.2016.0012 YÖKSİS TR Index SJR Q3 JCR Q3 OpenAlex 45.9%
  16. 2017 Current practice of autologous hematopoietic progenitor cell mobilization in adult patients with multiple myeloma and lymphoma: The results of a survey from Turkish hematology research and education group (ThREG) Transfusion and Apheresis Science DOI 10.1016/j.transci.2017.11.010 YÖKSİS SJR Q3 JCR Q4 OpenAlex 16.3%
  17. 2017 A 80-Year-Old Woman with B-Cell Prolymphocytic Leukemia Hematology Reports DOI 10.4081/hr.2017.6995 YÖKSİS SJR Q3 JCR Q4 OpenAlex 3.3%
  18. 2017 Is Cytomegalovirus Surveillance Necessary for Patients With Low Reactivation Risk in an Autologous Hematopoietic Cell Transplantation Setting? Transplantation Proceedings DOI 10.1016/j.transproceed.2017.05.007 YÖKSİS SJR Q3 JCR Q4 OpenAlex 66.8%
  19. 2017 BK Virus-associated Hemorrhagic Cystitis in Patients with Allogeneic Hematopoietic Cell Transplantation: Report of Three Cases. Hematology Reports DOI 10.4081/hr.2017.7205. YÖKSİS SJR Q3 JCR Q4 OpenAlex 66.8%
  20. 2017 Coexistence of chronic lymphocytic leukemia and multiple myeloma, do the roots of these entities originate from the same place? Clinical case reports DOI 10.1002/ccr3.951 YÖKSİS SJR Q4 JCR Q3 OpenAlex 69.2%

Akademisyenlere dön